325 related articles for article (PubMed ID: 24028896)
1. Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy.
Wu X; Wu M; Zhao JX
Nanomedicine; 2014 Feb; 10(2):297-312. PubMed ID: 24028896
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional mesoporous silica nanoplatform based on silicon nanoparticles for targeted two-photon-excited fluorescence imaging-guided chemo/photodynamic synergetic therapy in vitro.
Li S; Zhang Y; He XW; Li WY; Zhang YK
Talanta; 2020 Mar; 209():120552. PubMed ID: 31892096
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
[TBL] [Abstract][Full Text] [Related]
4. Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.
Wang Z; Liu G; Zheng H; Chen X
Biotechnol Adv; 2014; 32(4):831-43. PubMed ID: 24013011
[TBL] [Abstract][Full Text] [Related]
5. Advances in silica based nanoparticles for targeted cancer therapy.
Yang Y; Yu C
Nanomedicine; 2016 Feb; 12(2):317-32. PubMed ID: 26706409
[TBL] [Abstract][Full Text] [Related]
6. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
[TBL] [Abstract][Full Text] [Related]
7. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
8. Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.
Butler KS; Durfee PN; Theron C; Ashley CE; Carnes EC; Brinker CJ
Small; 2016 Apr; 12(16):2173-85. PubMed ID: 26780591
[TBL] [Abstract][Full Text] [Related]
9. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
10. Bioengineered nanoparticles for siRNA delivery.
Kozielski KL; Tzeng SY; Green JJ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):449-68. PubMed ID: 23821336
[TBL] [Abstract][Full Text] [Related]
11. Shape matters when engineering mesoporous silica-based nanomedicines.
Hao N; Li L; Tang F
Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
[TBL] [Abstract][Full Text] [Related]
12. Silica nanoparticles: Biomedical applications and toxicity.
Huang Y; Li P; Zhao R; Zhao L; Liu J; Peng S; Fu X; Wang X; Luo R; Wang R; Zhang Z
Biomed Pharmacother; 2022 Jul; 151():113053. PubMed ID: 35594717
[TBL] [Abstract][Full Text] [Related]
13. Advances in the Use of Multifunctional Mesoporous Silica Nanoparticles and Related Nanomaterials as Carriers for the Cancer Treatment.
Song C; Wang X; Wang Y; Yu H; Cui Y; Ma T
Curr Drug Metab; 2018; 19(2):131-141. PubMed ID: 28758578
[TBL] [Abstract][Full Text] [Related]
14. Targeting Cancer Cells with Photoactive Silica Nanoparticles.
Borzęcka W; Trindade T; Torres T; Tomé J
Curr Pharm Des; 2016; 22(39):6021-6038. PubMed ID: 27306094
[TBL] [Abstract][Full Text] [Related]
15. Tumor-targeting glycol chitosan nanoparticles as a platform delivery carrier in cancer diagnosis and therapy.
Lee SJ; Min HS; Ku SH; Son S; Kwon IC; Kim SH; Kim K
Nanomedicine (Lond); 2014 Aug; 9(11):1697-713. PubMed ID: 25321170
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles in recent photodynamic therapy applications.
Bayir S; Barras A; Boukherroub R; Szunerits S; Raehm L; Richeter S; Durand JO
Photochem Photobiol Sci; 2018 Nov; 17(11):1651-1674. PubMed ID: 30022180
[TBL] [Abstract][Full Text] [Related]
17. Chemo-photodynamic combined gene therapy and dual-modal cancer imaging achieved by pH-responsive alginate/chitosan multilayer-modified magnetic mesoporous silica nanocomposites.
Yang H; Chen Y; Chen Z; Geng Y; Xie X; Shen X; Li T; Li S; Wu C; Liu Y
Biomater Sci; 2017 May; 5(5):1001-1013. PubMed ID: 28327716
[TBL] [Abstract][Full Text] [Related]
18. External heavy-atomic construction of photosensitizer nanoparticles for enhanced in vitro photodynamic therapy of cancer.
Zhou L; Wei S; Ge X; Zhou J; Yu B; Shen J
J Phys Chem B; 2012 Oct; 116(42):12744-9. PubMed ID: 22984941
[TBL] [Abstract][Full Text] [Related]
19. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
20. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
